Background. Pain is the most frequent complaint of burn-injured patients. Opioids are commonly used in the course of treatment. However, there is a lack of rodent studies that examine the differential effects of various opioids on burn pain.
Introduction
Unrelieved burn injury pain is a significant public health problem. Fortunately, the incidence of burn injury in the United States has declined significantly over the last two decades. Nonetheless, according to current estimates, approximately 450,000 burn injury victims need emergency care annually, and 40,000 require hospitalization [1, 2] . Burn treatment has improved tremendously over the past two decades, resulting in a significant increase in patients surviving major burns [1] . However, burn pain remains undertreated [3] . This results in pain being the most frequent complaint of burn-injured patients [4] [5] [6] [7] .
Opioids (a term that refers to opiates, the natural products obtained from the opium poppy, and synthetic opioids) are the most commonly used drugs for managing moderate to severe pain [8] [9] [10] . They are also commonly used in the course of burn pain management [3, 7] . Stronger opioids, such as oxycodone and morphine, are used to control for severe pain, and very high-potency opioids such as fentanyl are provided as analgesic adjuvants for controlling procedural pain associated with painful but short procedures such as bandage changes and skin debriding following burn injuries [4, 7, [11] [12] [13] [14] . Hydrocodone, which is pharmacologically considered a weaker opioid, is not usually used in the treatment of burn injuries, and when hydrocodone is used it is likely to be administered only in the advanced stages of healing and during rehabilitation.
Currently, the opioids most commonly used for pain management are high-affinity opioid receptor agonists. These high-affinity agonists (e.g., oxycodone, hydromorphone, morphine, etc.) are often used somewhat interchangeably, with dose adjustments for their relative potency (which is dependent upon their affinity for the opioid receptors). Meanwhile, low-affinity opioids are often avoided for severe pain due to their expected low potency. This is based on the historic notion that multiple different agonists (such as opioid analgesics) can bind to a particular receptor with different affinities; however, all agonists (i.e., all opioids) engage the same intracellular signaling pathways once bound. Notably, recent studies suggest that different opioid analgesics (opioid agonists) engage different downstream signaling effects within the cell, despite binding to and activating the same receptor [15] [16] [17] [18] [19] [20] [21] . For example, it has been shown that G-protein coupled receptors can signal via a classical pathway activated via G-proteins and a noncanonical pathway activated via b-arrestin (bArr) [22] [23] [24] . Bias toward G-protein coupled signaling was demonstrated to increase analgesia, while bias toward bArr-dependent pathways mediates negative opioid-related outcomes [25] [26] [27] [28] . Additional studies are still required to fully appreciate the spectrum of signaling biases of various opioid agonists and how they relate to their clinical effects. Nonetheless, this recent recognition implies that, in contrast to the status quo, an opioid with lower affinity (i.e., a weak opioid) might activate the opioid receptor differently than an opioid with higher affinity (i.e., a strong opioid) and not just to a lesser degree. In turn, this means that a weak opioid might have beneficial effects that a strong opioid lacks, depending upon differences in bias between different secondary signaling pathways.
Unfortunately, there is not yet enough data from rodent studies that examine the differential effects of various opioids on burn pain to implement an evidence-based decision. This study employed a rodent burn model in which burn-induced mechanical allodynia was developed during the 28 days following the burn injury. This study compares the antinociceptive effects of morphine, oxycodone, and hydrocodone, as well as their abilities to suppress the development of burn-induced mechanical allodynia and restore levels of pain sensitivity to levels observed in control, sham animals.
Methods

Animals
All animal procedures were conducted in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals and were approved by the Texas A&M Institutional Animal Care and Use Committee. Male C57BL/6 mice, purchased from Harlan Laboratories (Houston, TX, USA), were housed three to five per cage with food and water ad libitum. They were acclimated to the temperature-controlled (21 6 2 C) vivarium with a 12-hour/12-hour light/dark cycle (lights on at 07:00) for five to seven days prior to the start of experiments. Similar to our previous studies [29] [30] [31] [32] [33] , mice were treated starting at postnatal day (PND) 28. This age was chosen given that burn injuries are very common in children, representing the fifth most common cause of nonfatal childhood injuries [34] . Additionally, we examined only male mice given that, according to the American Burn Association, 69% of burn victims are males [1] . Further studies should examine other ages as well as females, especially considering sex-dependent pain sensitivity differences [35] .
Burn
The burn model used in this study was modified from studies in rats [36] . Mice were anesthetized (minimizing the animals' movement and any unanticipated deviation from expected injury severity), and a burn injury was induced by holding the dorsal portion of the hindpaw pressed against a premade template with a window of 4.5 mm Â 5.0 mm. Then, the exposed dorsal surface of the hindpaw (through the hole) was immersed into a hot water bath (85 C) for five seconds. The burn injury was limited by the template to an area of approximately 0.24 cm 2 with the toes and upper leg protected from the water by the template. A sham injury was induced by immersing the dorsal part of the right hindpaw into a 37 C water bath for five seconds using the same method. Silver sulfadiazine cream (USP 1% Watson labs NDC 0591-0810-83) was applied to the injuries twice daily until scar tissue was formed. The burn procedure utilized in this experiment produced a consistent blister, which began forming within approximately two to three hours, was fully formed within 24 hours, and remained for five to seven days. This visually corresponds with a second-degree burn. Our observed burn severity corresponds with the second-degree burns observed by Wang et al. [36] .
Drugs
Mice were treated orally with morphine, oxycodone, hydrocodone (via gavage, 20 or 40 mg/kg, 10 mL/kg), or saline twice daily (10 AM and 6 PM) for 28 days beginning the evening of the day of injury (day 1, 6 PM). Drugs were purchased from Sigma-Aldrich Chemicals (St. Louis, MO, USA). These doses represent base plus salt concentrations. For oxycodone, these doses roughly correspond to 18 and 36 mg/kg base. For hydrocodone, these doses roughly correspond to 13 and 26 mg/kg base. For morphine, these doses roughly correspond to 15 and 30 mg/kg base. These doses were selected to represent equianalgesic doses, as confirmed by our previous studies [30, 37] . Please note that there are speciesand age-dependent differences in the pharmacokinetics of opioids (absorption, metabolism, etc.), as well as in the levels and distribution of opioid receptors, which are likely involved in the underlying response for these oral doses to represent equianalgesic doses, and therefore these doses may not be equianalgesic in other models.
Von Frey Filaments Test
Similar to our previous studies [31] , mechanical allodynia was assessed using nylon von Frey filaments (Touch Test [von Frey] Sensory Evaluator Kit, Stoelting Co., Wood Dale, IL, USA) [38] . Mice were placed in a Plexiglas cylinder (D: 3 in x H: 6 in) atop a mesh platform (made of aluminum window screen, with 1 mm 2 holes). The mechanical allodynia test was performed as described by Wang et al. [36] . Briefly, Von Frey filaments were applied to the plantar surface of the hind paw (of both feet) five times until a withdrawal response was observed at least once. The response was defined as a rapid withdrawal of the paw, with toes curling, from the mesh. If no response was observed after five applications of the fiber, the next stiffer fiber was applied to the same paw until a response was evoked; however, if a response was observed, a less stiff fiber was applied until no response was observed over five trials. The final filament that produced a response was recorded for that trial.
Experimental Design
The extremely visible nature of the burn injury as well as locomotor activity while on opioids makes blindness to sham vs burn injury condition as well the drug vs saline impossible, even for experimenters naïve to conditions. Drug injections and behavioral testing logs were kept separate to keep the experimenter blind to the specific opioid injected. Mice arrived at PND 21 and were habituated to the facility, experimenter, and handling until PND 28, when they were first examined for their baseline pain sensitivity thresholds. The following day, on experimental day 1, mice were subjected to burn or sham injury and opioid treatment began. All mice were tested again on days 4, 7, 11, 14, 21, and 28 following the burn injury. On each testing day, they were first examined for baseline responses to the von Frey filaments. Immediately following the baseline test, they were injected with the corresponding opioid dose or saline; this drug administration was their morning dose. One hour later, their responses to the von Frey filaments were recorded again. The sample size of each experimental group is summarized in Table 1 .
Data Analysis
The development of burn-induced mechanical allodynia was assessed by comparing the daily pretreatment pain sensitivity threshold scores (in g) of burn-saline animals vs sham-saline animals ( Figure 1 ). The development of opioid-induced hyperalgesia (OIH) was assessed by comparing the daily pretreatment pain sensitivity threshold scores (in g) of sham animals receiving the various opioids vs sham-saline animals ( Figure 2 , A-C). The effect of opioids to alter the development of burn-induced mechanical allodynia was assessed by comparing the daily pretreatment pain sensitivity threshold scores (in g) of burned animals receiving opioids vs burn-saline animals ( Figure 2 , A-C). The pain-relieving effects of the drugs one hour after administration were analyzed by comparing the daily post-treatment pain sensitivity threshold scores (in g) of burned animals receiving opioids vs burn-saline animals ( Figure 2 , D-F). The antinociceptive effects of the various drugs were analyzed by computing the daily differences between post-and pretreatment pain sensitivity threshold scores (in g) ( Figure 3 ). Data were analyzed using a split-plot analysis of variance (ANOVA; SPSS Statistics 20, Somers, NY, USA) with between-group factors of treatment (opioid, saline) and a within-group factor of time (day). Post hoc contrasts between each treatment group were computed using Bonferroni procedure. Differences with P values of less than 0.05 were deemed statistically significant. Results are presented as mean 6 SEM.
Results
The Effect of Burn Injury on Pain Sensitivity Threshold
To verify that the burn injury model resulted in a significant development of mechanical allodynia, we compared the pain sensitivity thresholds between sham-saline and burnsaline animals ( Figure 1 ). Two-way repeated ANOVA revealed a significant main effect of injury (F(1, 32) ¼ 78.21, P < 0.0001), a significant main effect of day (F(6, 192) ¼ 21.50, P < 0.0001), and a significant interaction between day and injury (F(6, 192) ¼ 22.24, P < 0.0001). Bonferroni post hoc comparison revealed that the pain sensitivity threshold significantly decreased within four days following the injury and continued to decrease during the course of the 28-day study ( Figure 1 ). This marked decrease in pain sensitivity threshold indicates that significant levels of mechanical allodynia were developed in the burn-injured foot within four days of injury and were intensified during the course of the 28-day study.
Effects of Various Opioids on the Development of OIH and Burn-Induced Mechanical Allodynia
Hydrocodone Two-way repeated ANOVA revealed a significant main effect of injury (F(5, 78) ¼ 44.22, P < 0.0001), a significant main effect of day (F(6, 468) ¼ 67.58, P < 0.0001), and a significant interaction between day and injury (F(6, 468) ¼ 9.26, P < 0.0001). Bonferroni post hoc comparison revealed that the burn-hydro-40 animals had a small but significantly higher baseline pain sensitivity threshold than the sham-saline animals. However, their baseline did not significantly differ from the burn-saline animals or any of the other experimental groups. Hydrocodone resulted in only minimal OIH ( Figure 2A ). Specifically, a significant decrease in pain sensitivity threshold was observed in the sham-hydro-20 vs sham-saline animals on day 21 postinjury. This was not observed in the sham-hydro-40 animals. Rather, a small but significant increase in pain sensitivity thresholds was observed in the sham-hydro-40 animals on day 4 postinjury.
Hydrocodone was very effective in minimizing the development of burn-induced mechanical allodynia ( Figure  2A ). Bonferroni post hoc comparison revealed that, compared with the burn-saline animals, the burn-hydro-40 animals had significantly decreased pain sensitivity (i.e., increased pain sensitivity thresholds) starting at seven days postinjury and continued up through the end of the 28-day study. The burn-hydro-20 animals had significantly decreased pain sensitivity only on days 11 and 28 postinjury.
Oxycodone Two-way repeated ANOVA revealed a significant main effect of injury (F(5, 78) ¼ 48.96, P < 0.0001), a significant main effect of day (F(6, 468) ¼ 51.10, P < 0.0001), and a significant interaction between day and injury (F(6, 468) ¼ 5.60, P < 0.0001). Bonferroni post hoc comparison revealed that the sham-oxy-40 animals had a small but significantly higher baseline pain sensitivity threshold than the sham-saline animals ( Figure 2B ). OIH was not developed in the sham animals at either of the doses ( Figure 2B ). Importantly, oxycodone had no significant effects on burn-induced mechanical allodynia at any time point ( Figure 2B ). Bonferroni post hoc comparison revealed that neither of the doses significantly changed pain sensitivity threshold at any given time as compared with burn-saline animals.
Morphine Two-way repeated ANOVA revealed a significant main effect of injury (F(5, 76) ¼ 47.84, P < 0.0001), a significant Figure 1 The development of mechanical allodynia following burn injury. Mice were examined for their baseline pain sensitivity thresholds. Then, they were subjected to sham or burn injury and treated twice daily with saline. The original baseline and daily pretreatment pain sensitivity threshold scores (in g) are shown. *Indicates significant difference (P < 0.01) from sham-saline animals. Results are presented as mean 6 SEM.
main effect of day (F(6, 456) ¼ 78.62, P < 0.0001), and a significant interaction between day and injury (F(6, 456) ¼ 9.52, P < 0.0001). Bonferroni post hoc comparison revealed no significant differences in baseline pain thresholds. OIH was developed in the sham-mor-20, but not the shammor-40, animals ( Figure 2C ). Specifically, on days 11, 14, and 21 postinjury, a significant decrease in pain sensitivity threshold was observed in the sham-mor-20 animals vs sham-saline animals. In contrast, small but significant increases in pain sensitivity thresholds were observed on days 4 and 11 postinjury in the sham-mor-40 animals. Morphine had minimal effects on severity of burn-induced mechanical allodynia ( Figure 2C ). Bonferroni post hoc comparison revealed that the burn-mor-20 animals did not significantly differ in pain sensitivity threshold from the burn-saline animals. The burn-mor-40 animals had significantly reduced pain sensitivity (i.e., increased pain sensitivity threshold) only on day 14.
Effects of Various Opioids on Pain Sensitivity One Hour After Administration
Hydrocodone Two-way repeated ANOVA revealed a significant main effect of injury (F(5, 78) ¼ 65.91, P < 0.0001), a significant main effect of day (F(6, 468) ¼ 16.32, P < 0.0001), and a significant interaction between day and injury (F(6, 468) ¼ 12.15, P < 0.0001). Bonferroni post hoc comparison revealed an increased pain sensitivity threshold in the sham-hydro-40 animals on days 4, 7, 11, 14, and 28 ( Figure 2D ). However, increased pain sensitivity threshold in the sham-hydro-20 animals was observed only on day 4. Both doses increase pain sensitivity threshold in the burned animals starting at day 4 and continue to increase pain sensitivity threshold for the entire duration of the study. Notably, there were no significant differences between either the burn-hydro-20 or burn-hydro-40 vs the sham-saline animals, with the exception of burn-hydro-20 animals on day 21 . This means that pain sensitivity in the hydrocodone-treated burned animals was fully reversed to the levels observed in sham animals receiving no drugs ( Figure 2D ).
Oxycodone
Two-way repeated ANOVA revealed a significant main effect of injury (F(5, 78) ¼ 47.73, P < 0.0001), a significant main effect of day (F(6, 468) ¼ 15.59, P < 0.0001), and a significant interaction between day and injury (F(6, 468) ¼ 7.67, P < 0.0001). Bonferroni post hoc comparison revealed increased pain sensitivity threshold in sham-oxy-40 animals on days 4, 7, 11, and 14 ( Figure 2E ). However, increased pain sensitivity threshold in shamoxy-20 was observed only on day 7. The burn-oxy-40 animals had increased pain sensitivity thresholds starting from day 7 for the entire duration of the study. The burnoxy-20 animals had increased pain sensitivity threshold only on days 11, 14, and 28. However, levels of pain sensitivity were not fully reversed to levels observed in the sham-saline animals. A significant difference between Figure 2 The effects of various opioids on the development of opioid-induced hyperalgesia and burn-induced mechanical allodynia. Mice were examined for their baseline pain sensitivity thresholds. Then, they were subjected to sham or burn injury and treated twice daily for 28 days with saline, hydrocodone (A, D), oxycodone (B, E), or morphine (C, F). The original baseline and daily pretreatment (A, B, C) and post-treatment (D, E, F) pain sensitivity threshold scores (in g) are shown. *Indicates significant difference (P < 0.05) from sham-saline animals. § Indicates significant difference (P < 0.05) from burn-saline animals. Results are presented as mean 6 SEM.
both the burn-oxy-20 and burn-oxy-40 vs sham-saline was observed on days 7, 11, 21, and 28 ( Figure 2E ).
Morphine
Two-way repeated ANOVA revealed a significant main effect of injury (F(5, 76) ¼ 51.10, P < 0.0001), a significant main effect of day (F(6, 456) ¼ 17.11, P < 0.0001), and a significant interaction between day and injury (F(6, 456) ¼ 10.39, P < 0.0001). Bonferroni post hoc comparison revealed increased pain sensitivity thresholds in sham-mor-40 animals starting on day 4 and continuing for the remainder of the study ( Figure 2F ). However, this was not observed in the sham-mor-20 animals. The burn-mor-40 animals had increased pain sensitivity thresholds beginning on day 7 and continuing for the remainder of the study. The burn-mor-20 animals had increased pain sensitivity thresholds only on days 11, 14, and 28. However, levels of pain sensitivity were not fully reversed to levels observed in the sham-saline animals. A significant difference between both the burnmor-20 and burn-mor-40 vs sham-saline was observed on days 7, 11, 21, and 28 ( Figure 2F ).
The Antinociceptive Effects of the Various Opioids
Morphine, oxycodone, and hydrocodone had similar antinociceptive effects in the sham animals ( Figure 3, A and B) . Two-way repeated ANOVA revealed a significant main effect of opioid (F(6, 63) ¼ 35.80, P < 0.0001) and a significant main effect of day (F(5, 315) ¼ 5.19, P < 0.0001), but no significant interaction between day and drug (F(30, 315) ¼ 1.49, P > 0.05, ns). As expected, Bonferroni post hoc comparison revealed that all opioids significantly increased pain sensitivity thresholds as compared with saline. For the 20 mg/kg dose ( Figure 3A) , two-way repeated ANOVA revealed no significant main effect of opioid (F(2, 24) ¼ 0.41, P > 0.05, ns), no significant main effect of day (F(5, 120) ¼ 1.46, P > 0.05, ns), and no significant interaction between day and opioid (F(10, 120) ¼ 0.88, P > 0.05, ns). This indicates that there were no significant differences between the opioids in their antinociceptive effects, as well as no development of tolerance over time. For the 40 mg/kg dose ( Figure  3B ), two-way repeated ANOVA revealed a significant main effect of day (F(5, 140) ¼ 5.74, P < 0.0001). However, there was no significant main effect of opioid (F(2, 28) ¼ 0.98, P > 0.05, ns), and no significant interaction between day and opioid (F(10, 140) ¼ 0.59, P > 0.05, ns). This indicates that tolerance was developed over time at this dose. However, there were no significant differences between the opioids in their antinociceptive effects and no significant differences in the development of tolerance between the various opioids.
Similarly, morphine, oxycodone, and hydrocodone had similar antinociceptive effects in the burn-injured animals ( Figure 3, C and D) . Two-way repeated ANOVA revealed a significant main effect of opioid (F(6, 105) ¼ 16.92, P < 0.0001) and a significant main effect of day (F(5, 525) ¼ 2.34, P < 0.05), but no significant interaction between day and drug (F(30, 525) ¼ 1.36, P > 0.05, ns). As expected, Bonferroni post hoc comparison revealed that all opioids significantly increased pain sensitivity thresholds as compared with saline. For each dose, two-way repeated ANOVA revealed a significant main effect of day (20 mg/kg: F(5, 230) ¼ 2.75, P < 0.05; 40 mg/kg: F(5, 190) ¼ 3.10, P < 0.01). However, there was no significant main effect of opioid (20 mg/kg: F(2, 46) ¼ 0.83, P > 0.05, ns; 40 mg/kg: F(2, 38) ¼ 2.48, P > 0.05, ns) and no significant interaction between day and opioid (20 mg/kg: F(10, 230) ¼ 0.52, P > 0.05, ns; 40 mg/kg: F(10, 190) ¼ 0.98, P > 0.05, ns). This indicates that a small but significant antinociceptive tolerance was developed over time to both doses in burn-injured animals. However, there were no significant differences between the opioids in their antinociceptive effects and no significant differences in the development of tolerance between the various opioids.
Discussion
This study demonstrated that hydrocodone is effective in suppressing the development of burn-induced mechanical allodynia, while oxycodone and morphine show reduced ability to do so. Specifically, this study employed the von Frey Filaments test to determine mechanical sensitivity thresholds. As expected, burn injury resulted in a marked decrease in sensitivity thresholds, which indicates a marked increase in nociceptive sensitivity. None of the opioids had a significant effect on the development of this burn-induced mechanical allodynia in the first week following the burn injury. However, beginning at day 7 postburn and continuing until the end of the study, hydrocodone prevented worsening of the burn-induced mechanical allodynia. Both morphine and oxycodone had only minimal effects on the development of burn-induced mechanical allodynia. Although all opioids had similar antinociceptive effects, only hydrocodone fully reversed pain sensitivity to the levels observed in sham animals. Given that the antinociceptive effects are computed as the differences between the daily post-and pretreatment pain sensitivity threshold scores, this is likely a reflection of the lower daily pre-treatment pain sensitivity threshold scores in morphine-and oxycodone-treated animals vs hydrocodone-treated animals. Overall, these results indicate the superiority of hydrocodone in managing burn-induced mechanical allodynia pain as compared with the other opioids.
The differences between the various opioids in their effect on the development of burn-induced mechanical allodynia are unlikely to be explained solely by differences in pharmacokinetics. Morphine, administered orally, has a half-life of about two hours in rodents [39] and two to three hours in humans. The half-lives of oxycodone and hydrocodone have not been studied in rodents and are a little longer than morphine in humans. Hydrocodone, when administered orally, has a terminal half-life of about three to four hours in humans and a slightly shorter half-life in smaller animals like dogs [40, 41] . Hydrocodone is partially metabolized to the potent active metabolite hydromorphone [42] . In humans, the elimination half-life of hydromorphone is about three to four hours [43] , and in dogs it has a terminal half-life of about three hours [40] . Oxycodone, when administered orally, has a terminal elimination half-life of about three to four hours in humans [44, 45] . Oxycodone's major metabolites are noroxycodone, noroxymorphone, and oxymorphone, with elimination terminal half-lives of five to nine hours [45] . Thus, the superiority of the effect of hydrocodone, as compared with morphine and oxycodone, is unlikely to be explained solely by longer half-life. Nonetheless, a more thorough analysis of the pharmacokinetics of these drugs in rodents, as well as the effects of extended-release formulations of these opioids on the development of burn-induced pain, may be required.
Various opioids display differential affinities for the three opioid receptors, m-, d-, and j-opioid receptors (MOR, DOR, and KOR, respectively). Recently DOR was demonstrated to be involved in the control of mechanical pain while MOR was demonstrated to be involved in the control of heat pain [46] . However, the differences between the various opioids in their effect on the development of burn-induced mechanical allodynia are unlikely to be explained solely by differences in affinity to the different opioid receptors. Specifically, while all three drugs are most selective for MOR, morphine has higher affinities for DOR and KOR, while both hydrocodone and oxycodone have very low affinities for DOR and KOR [47, 48] . Moreover, hydrocodone and oxycodone share extremely similar affinity profiles for these receptors [47, 48] . If the difference in their effect on the development of burn-induced mechanical allodynia could be explained by their corresponding affinities, hydrocodone and oxycodone would be expected to demonstrate similar effects while morphine would be expected to differ in its effects.
The differences in the abilities of the various opioids to suppress the development of burn-induced mechanical allodynia are more likely based on differences in their pharmacodynamics. Various opioids were demonstrated to differentially modulate downstream signaling even when binding to and activating the same receptor [15, 49, 50] , a phenomenon termed ligand-directed signaling or biased agonism. Specifically, our previous studies demonstrate that, at equianalgesic dosages, morphine, hydrocodone, and oxycodone differentially alter the activation levels of the signaling molecules Akt and ERK, as well as the response to dopamine D2 receptor agonists, in ways unique to individual opioids [29, 30] . This phenomenon was also observed with other opioids [51] . Biased agonism at the opioid receptors is likely related to the ability of G-protein coupled receptors to signal via different mechanisms and the differential abilities of various opioids to activate those various mechanisms. These mechanisms include the canonical G-protein coupled signaling (GPCS) and the noncanonical G-protein independent signaling, which involves the scaffolding proteins betaArrestins (bArrs). For example, at both MOR and DOR, bias toward G-protein coupled signaling vs the bArrs pathway was demonstrated to be related to agonists' analgesic properties and the development of OIH [25, 52] . Additionally, mice lacking bArr2 show no development of tolerance to morphine, as well as an attenuation of naloxone-induced withdrawal [53] . These mice showed normal tolerance and withdrawal when treated with oxycodone, methadone, or fentanyl, which are known to signal via the same receptor. Different opioids have been shown to activate ERK differently [54] . Additionally, oxycodone and morphine have been demonstrated to differentially activate MOR in a bone cancer pain model [55] and show differential effects in relieving chronic neuropathic pain in clinical settings and mouse models [56] [57] [58] [59] . Lastly, various opioids can have very different levels of side effects, despite equal potency to relieve pain [30, 60] . Thus, the differential effects of the various opioids on suppressing the development of burn-induced mechanical allodynia might be attributed to differential effects at the various opioid receptors as well as the differential effects of various opioids on activation levels of downstream signaling molecules at the same receptor.
OIH refers to abnormal pain sensitivity due to sensitization of pronociceptive mechanisms by opioids [61] [62] [63] . This abnormal pain sensitivity refers both to increased sensitivity to noxious stimuli and to increased painful responses to previously non-noxious stimuli. Importantly, in this study, various opioids demonstrated different degrees of OIH development. This might be due to differentially biased signaling (e.g., G-protein coupled vs bArr pathways) at the MOR and/or DOR [25, 52] . Notably, for both morphine and hydrocodone, the 20 mg/kg dose resulted in development of OIH, but the 40 mg/kg dose did not. This is surprising given that, clinically, treatment with higher doses of opioids is thought to be associated with increased OIH. It is possible that the differences in the effects of the low vs high doses in the current study are related to differences in clearance. The 20 mg/kg dose is likely to be cleared out faster than the 40 mg/kg dose, leaving the animals twice daily with longer periods of ultra-low levels of opioids in their system. Ultra-low levels of opioids were demonstrated to be faster in generating OIH as compared with higher doses [64] [65] [66] .
Lastly, it is interesting that in the current study oxycodone demonstrates approximately equivalent ability to alleviate burn-related pain as morphine. This finding seemingly contradicts prior findings in both humans and animals that oxycodone is superior to morphine to treat neuropathic-like pain states [56] [57] [58] [59] and may indicate model-specific differences (e.g., species, age, pain model, drug administration route and/or time course, etc.), which should be considered when comparing opioids in terms of efficacy and risk. This finding is also intriguing given the failure of oxycodone to produce OIH in sham animals at either dose, which taken alone would imply a superiority of oxycodone to the other drugs, which was not borne out in any of the other measures in this study.
This study employed a rodent burn model in which burn-induced secondary mechanical allodynia was developed during 28 days following a burn injury. It demonstrated that hydrocodone is effective in reducing the development of burn-induced mechanical allodynia. In contrast, morphine and oxycodone have minimal effects on the development of burn-induced mechanical allodynia. The abnormal pain sensitivities that develop as a result of burn injuries are very difficult to treat and remain a significant public health problem. More rodent studies are required to improve our understanding of the differences among the currently available opioid analgesics in order to optimize the care provided to burn victims as well as those suffering from other pain modalities.
